Prevalence of cancer as a comorbid in COVID-19 patients and their characteristics: a meta-analysis study

Background: Cancer patients are considered susceptible to coronavirus disease (COVID-19) due to an immunosuppressive state. This study determined the prevalence of cancer as a comorbid in COVID-19 patients, severe events, case fatality rate, history of anticancer therapy associated with severe event...

Descripción completa

Detalles Bibliográficos
Autores principales: Sitanggang, Johan S., Siregar, Kamal B., Sitanggang, Henry H., Sprinse Vinolina, Noverita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9382154/
https://www.ncbi.nlm.nih.gov/pubmed/36051540
http://dx.doi.org/10.12688/f1000research.53539.2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9382154/
https://www.ncbi.nlm.nih.gov/pubmed/36051540
http://dx.doi.org/10.12688/f1000research.53539.2

Ejemplares similares